Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q3 2015 · —
Revenue$2.04B$2.04B+9.6% vs Q3 2014 Net Income-$198.00M-$198.00MN/M vs Q3 2014 EPS Diluted-$0.15-$0.15N/M vs Q3 2014 Gross Profit$1,349,000,000+4.1% Operating Income-$299,000,000N/M Operating Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
$408,000,000
+17.9%
Free Cash Flowderived$338,000,000+16.6% Margins · derivedGross margin66.2%−3.5 pt vs Q3 2014
Operating margin-14.7%−18.1 pt vs Q3 2014
Net margin-9.7%−12.0 pt vs Q3 2014